A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
Søren Brunak presented deep learning approaches for analyzing disease trajectories using data from 7-10 million patients in Denmark and the USA. The models predict future outcomes like mortality and specific diagnoses, such as pancreatic cancer, using 15-40 years of patient data. Disease trajectories and explainable AI can generate hypotheses for molecular-level investigations into causal aspects of disease progression. Why it matters: This research demonstrates the potential of large-scale patient data and AI to improve disease prediction and generate hypotheses for further investigation into disease mechanisms relevant to regional healthcare systems.
Researchers at MBZUAI have developed a new machine learning method called survival rank-n-contrast (SurvRNC) to improve survival models for cancer prognoses. The method is designed to predict survival times for head and neck cancer patients using multimodal data while accounting for censored data (missing values). Numan Saeed presented the team’s work at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: Accurate prognoses can significantly improve patient outcomes, and this research contributes to advancements in machine learning techniques for handling complex and incomplete medical data.
MBZUAI researchers developed Human-in-the-Loop for Prognosis (HuLP), a new AI system designed to help physicians assess cancer progression by providing information about its predictions and allowing user intervention. The system aims to foster collaboration between physicians and AI, rather than replacing doctors. It was presented at the 27th International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Why it matters: This research highlights the potential of AI to augment physician expertise in critical areas like cancer prognosis, improving patient care and treatment decisions.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
MBZUAI Professor Agathe Guilloux developed the SigLasso model to forecast hospitalizations using real-time data from Google and Météo France during the COVID-19 pandemic. The model integrates mobility data and weather patterns to predict hospitalization rates 10-14 days in advance. SigLasso outperformed industry standards like GRU and Neural CDE in reducing reconstruction error. Why it matters: This research demonstrates the potential of AI to improve healthcare resource allocation and crisis management by accurately predicting patient flow using readily available data.
Eran Segal from Weizmann Institute of Science presented The Human Phenotype Project, a large-scale prospective cohort with over 10,000 participants. The project aims to identify novel molecular markers and develop prediction models for disease onset using deep profiling. The profiling includes medical history, lifestyle, blood tests, and molecular profiling of the transcriptome, genetics, microbiome, metabolome and immune system. Why it matters: Such projects demonstrate the growing focus on personalized medicine in the region, utilizing advanced AI and machine learning techniques for disease prevention and treatment.
A retrospective study in Abu Dhabi, UAE, developed a machine learning-based prognostic system to predict the risk of seven complications in COVID-19 patients using data from 3,352 patient encounters. The system, trained on data from the first 24 hours of admission, achieved high accuracy (AUROC > 0.80) in predicting complications like AKI, ARDS, and elevated biomarkers in geographically split test sets. The models primarily used gradient boosting and logistic regression.